Tag: Hemophilia B

July 4, 2018

5 Top NASDAQ Pharma Stocks of Q2 2018

About half way through 2018 finishing the second quarter, the INN takes a look at the 5 top pharma stocks...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 12, 2018

Catalyst Biosciences Announces Korean Ministry of Food and Drug Safety Approves Addition of Sixth Cohort to the Phase 1/2 Trial of CB 2679d/ISU304

Catalyst Biosciences (Nasdaq:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced that the...
February 26, 2018

Catalyst Biosciences Announces Manufacturing Agreement with AGC Biologics

Catalyst Biosciences (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced that they...
February 9, 2018

Catalyst Biosciences Announces Positive Top-Line Data from Phase 1/2 Study of Subcutaneous CB

Catalyst Biosciences (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced top-line data...
January 23, 2018

Two Biotech M&A's Total $20 Billion, Ignites Hope for More Deals

Monday, Celgene and Sanofi made a big impact for this year's biotech industry.
August 8, 2017

uniQure Shares Financial Results for Q2 2017

uniQure reported their financial results for the second quarter of 2017.